Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple-Negative Breast Cancer
Interventions: DRUG: JS001|DRUG: Nab-Paclitaxel|DRUG: Placebo|DRUG: Nab-Paclitaxel
Sponsor: Shanghai Junshi Bioscience Co., Ltd.